BioPharma
Korean Biopharma Market to Double Biopharma Exports By 2030
The South Korean government has gone on to hold the Bio Innovation Roundtable at Songdo Convensia in Incheon as per the theme K-Bio: Accelerating Innovation. The Ministry of Food and Drug Safety, the Ministry of Economy and Finance, the...
News
Matica Bio Gets a U.S. Biotech Commercial Manufacturing Deal
Matica Biotechnology, Inc., which happens to be a leading contract development and manufacturing organization (CDMO) that specializes in viral vector manufacturing in terms of cell and gene therapies, announced on September 15, a strategic commercial manufacturing deal along with...
News
The Latest Breakthroughs in Dental Treatments
Dental care has moved well beyond fillings and routine cleanings. In the past few years, the field has seen fast-moving advances across regenerative medicine, digital manufacturing, artificial intelligence (AI) and minimally invasive therapies. These breakthroughs promise better diagnostics, faster...
News
How Can Digital Tools Improve Medication Adherence in Patients?
Medication adherence has long been one of healthcare’s toughest challenges. Even the most effective treatment plan fails if patients don’t take their medications consistently. This isn’t just a patient-level problem, though; it has massive implications for healthcare systems, pharmaceutical...
BioPharma
Russia, Vietnam Collaborate on Biopharma Technology Transfer
Russia and Vietnam have gone on to officially formalize a major collaboration in healthcare, with Russia going ahead with the biopharma technology transfer to Vietnam.
It is well to be noted that this agreement was officially concluded at a signing...
Business & Industry
Trump Order to Go Heavy on D2C Pharmaceutical Ads
US President Donald Trump is all set to order his health department to go ahead and crack down on direct-to-consumer (D2C) pharmaceutical advertising as per a new memorandum that was inked on September 9, 2025.
This push, which happens to...
Business & Industry
Is US Planning Executive Order on Chinese Pharma Companies?
It is worth noting that the pharmaceutical sector’s recent source of novel molecules may as well be coming under threat. Apparently, it is the White House which is reportedly preparing an executive order that is going to place restrictions...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
















